Yeo, Leonard L. L.
Holmberg, Ake
Mpotsaris, Anastasios
Söderman, Michael
Holmin, Staffan
Kuntze Söderqvist, Asa
Ohlsson, Marcus
Bhogal, Pervinder
Gontu, Vamsi
Andersson, Tommy
Brouwer, Patrick A.
Article History
Received: 21 January 2018
Accepted: 22 February 2018
First Online: 22 March 2018
Compliance with ethical guidelines
:
: L.L. L. Yeo has received substantial grant funding from the National Medical Research Council (NMRC), Singapore, substantial grant funding from Ministry of Health (MOH), Singapore and moderate grant funding from I2R, A‑STAR, Singapore. M. Söderman is consultant for Medtronic, Cerenovus/Neuravi and Neurvana. P. Bhogal is consultant for Neurvana. T. Andersson is a consultant for Ablynx, Amnis Therapeutics, Medtronic, Cerenovus/Neuravi, Rapid Medical and Stryker. P. A. Brouwer is consultant for Medtronic, Stryker, Cerenovus/Neuravi, and BALT. A. Holmberg, A. Mpotsaris, S. Holmin, A. Kuntze Söderqvist, M. Ohlsson, and V. Gontu declare that they have no competing interests.
: Institutional ethics review board approval for this study was obtained from the regional ethical committee in Stockholm (regionala etikprövningsnämnden i Stockholm) Diarienr:2016/1041-31/4.